FDA.reportPublic FDA data

Adynovate 1 UNT Injection

RxCUI
1741409
RxNorm name
Adynovate 1 UNT Injection
Display name
Adynovate 1 UNT Injection
Full name
Adynovate 1 UNT Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125566AdynovateAntihemophilic Factor (Recombinant), PEGylated351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ef290433-997f-4e98-86d6-42f6a99d6d18Adynovate 1 UNT Injection [PSN] · antihemophilic factor (recombinant) pegylated 1 UNT Injection [Adynovate] [SBD] · Adynovate 1 UNT Injection [SY]323These highlights do not include all the information needed to use ADYNOVATE ® safely and effectively. See full prescribing information for ADYNOVATE. ADYNOVATE, (Antihemophilic Factor, Recombinant, PEGylated) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 201520251016